Darshan Ghia

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Graeme J. Hankey, Maree L. Hackett, Osvaldo P. Almeida et al. · The Lancet Neurology · 2020 · 145 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy et al. · The Lancet · 2024 · 125 citations · Full text

Medicine, Neurology, Cerebrovascular Surgery +11

Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Andrew M. Demchuk et al. · The Lancet · 2025 · 54 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial

Chris Bladin, N. Wah Cheung, Helen M. Dewey et al. · Stroke · 2023 · 34 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17